Fjordside L - Search Results

1

A typical case of tick-borne encephalitis.

Mens H, Thorsteinsson K, Fjordside L, Lebech AM. Mens H, et al. Among authors: fjordside l. Ugeskr Laeger. 2023 Oct 23;185(43):V07230460. Ugeskr Laeger. 2023. PMID: 37921110 Free article. Danish.

2

Using 18F-FDG PET/CT to rule out Richter transformation as cause of deterioration in a patient with chronic lymphatic leukemia and severe COVID-19: A case report.

Fjordside L, Mens H, Asmar A. Fjordside L, et al. Medicine (Baltimore). 2021 Nov 5;100(44):e27545. doi: 10.1097/MD.0000000000027545. Medicine (Baltimore). 2021. PMID: 34871217 Free PMC article.

3

Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms.

Mens H, Fjordside L, Gynthersen R, Ørbaek M, Andersen ÅB, Andreasson U, Blennow K, Sellebjerg F, Zetterberg H, Lebech AM. Mens H, et al. Among authors: fjordside l. Eur J Neurol. 2023 May;30(5):1371-1377. doi: 10.1111/ene.15707. Epub 2023 Feb 24. Eur J Neurol. 2023. PMID: 36692938

4

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis.

Mens H, Fjordside L, Gynthersen RMM, Ørbæk MT, Andersen ÅB, Andreasson U, Blennow K, Sellebjerg F, Zetterberg H, Lebech AM. Mens H, et al. Among authors: fjordside l. J Cent Nerv Syst Dis. 2022 Jul 7;14:11795735221098126. doi: 10.1177/11795735221098126. eCollection 2022. J Cent Nerv Syst Dis. 2022. PMID: 35832609 Free PMC article.

5

Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART.

Mens H, Fjordside L, Fonager J, Gerstoft J. Mens H, et al. Among authors: fjordside l. Infect Dis Rep. 2022 Jun 22;14(4):501-504. doi: 10.3390/idr14040053. Infect Dis Rep. 2022. PMID: 35893472 Free PMC article.

6

Helicobacter trogontum Bacteremia and Lower Limb Skin Lesion in a Patient with X-Linked Agammaglobulinemia-A Case Report and Review of the Literature.

Fjordside L, Herløv C, Drabe CH, Andersen LP, Katzenstein TL. Fjordside L, et al. Pathogens. 2022 Oct 27;11(11):1247. doi: 10.3390/pathogens11111247. Pathogens. 2022. PMID: 36364998 Free PMC article.

7

Validation of a risk score to differentiate autoimmune and viral encephalitis: a Nationwide Cohort Study in Denmark.

Fjordside L, Nissen MS, Florescu AM, Storgaard M, Larsen L, Wiese L, von Lüttichau HR, Jepsen MPG, Hansen BR, Andersen CØ, Bodilsen J, Nielsen H, Blaabjerg M, Lebech AM, Mens H. Fjordside L, et al. J Neurol. 2024 May 18. doi: 10.1007/s00415-024-12392-3. Online ahead of print. J Neurol. 2024. PMID: 38761191

8

Opportunistic non-communicable diseases in times of COVID-19.

Hegelund MH, Fjordside L, Faurholt-Jepsen D, Christensen DL, Bygbjerg IC. Hegelund MH, et al. Among authors: fjordside l. APMIS. 2023 Jan;131(1):13-18. doi: 10.1111/apm.13274. Epub 2022 Oct 20. APMIS. 2023. PMID: 36177674

9

Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study.

Pedersen EB, Thomsen IM, Fjordside LS. Pedersen EB, et al. Among authors: fjordside ls. Am J Hypertens. 2005 Dec;18(12 Pt 1):1578-85. doi: 10.1016/j.amjhyper.2005.06.008. Am J Hypertens. 2005. PMID: 16364829 Clinical Trial.

10

The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteine.

Fjordside L, Jeppesen U, Eap CB, Powell K, Baumann P, Brøsen K. Fjordside L, et al. Pharmacogenetics. 1999 Feb;9(1):55-60. doi: 10.1097/00008571-199902000-00008. Pharmacogenetics. 1999. PMID: 10208643 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page